Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
ReviewMembrane rafts in Alzheimer's disease beta-amyloid production
Introduction
Alzheimer's disease (AD) is one of the major neurodegenerative diseases that is predominant among aged individuals. The principal pathological hall marks of AD, originally described by Alois Alzheimer a little over one hundred years ago, are the two lesions, neurofibrillary tangles and senile plaques, which are found at significantly higher frequency in the cortex and hippocampus in individuals afflicted with AD compared to age matched healthy individuals [1]. Eighty years later, the molecular composition of senile plaques was deciphered with the advent of advanced biochemical and genetic tools. Senile plaques consist of extracellular deposits of 39–42 amino acid-long amyloid-β (Aβ) peptides. Subsequent studies revealed that Aβ is released from a large type I transmembrane protein, termed amyloid precursor protein (APP), by the sequential proteolysis of a set of enzymes termed β- and γ-secretases. Identification of familial AD-linked mutations in APP gene launched the exploration of the cell biology of APP and these secretases to modulate Aβ production to attenuate disease pathology. A growing body of evidence indicates that changes in cholesterol homeostasis can influence Aβ production, and studies in neuronal and non-neuronal cells implicate cholesterol-enriched membrane microdomains, termed lipid rafts, in amyloidogenic processing of APP. However, the connection between cholesterol, lipid rafts and APP processing has not been completely understood, and controversy still exists. In this review, we will first describe the cell biology of APP, β- and γ-secretases followed by the mechanistic details of amyloidogenic processing. Then, we will elaborate on the current status of research addressing the importance of raft association of BACE1 and γ-secretase, and discuss potential raft targeting signals in the secretases and their unanticipated redundant role on amyloidogenic processing of APP.
Section snippets
An overview of APP and secretases
The APP gene is mapped to chromosome 21 and different isoforms of APP exist as a result of alternative splicing of the nascent transcript. Predominant isoforms include APP695, 751 and 770 which differ by the absence (APP695) or presence (APP751 and 770) of an extracellular Kunitz protease inhibitor (KPI) domain. APP695 is the major neuronal isoform whereas APP770 isoform is expressed in most other cell types. Direct correlation of APP overexpression and AD pathology is evident in Down's
The role of cholesterol in AD pathogenesis
Cholesterol has long been clinically associated with AD pathogenesis and this connection attracted many research groups to explore the underlying causal role of cholesterol on APP processing for therapeutic intervention. In fact, the brain is the most cholesterol-rich organ in our body, which can sequester 25% of total cholesterol even though it contributes to 2% of total body weight [45], [46]. Since, cholesterol is the main constituent of lipid rafts, it is imperative to understand the
Lipid rafts
Lipid rafts are dynamic and highly ordered membrane microdomains rich in cholesterol and sphingolipids that are distinct from surrounding membranes of unsaturated phospholipids. The average size of lipid rafts is estimated to be 50 nm in diameter, although several distinct raft domains can exist in a cell that are heterogeneous in size and life time [72], [73]. Lipid rafts concentrate select proteins and serve as a platform for cellular processes such as cell signaling, pathogen entry, cell
Cholesterol depletion
Selective targeting of BACE1 and γ-secretase processing of APP in lipid rafts is considered as an elegant therapeutic strategy to modulate Aβ production. Cholesterol is the main constituent of lipid rafts and depletion of cellular cholesterol by sequestering agent such as methyl-β-cyclodextrin disturb the integrity of lipid raft domains. Therefore, cholesterol depletion was used as an approach to displace secretases and APP from raft domains. As a consequence, APP processing to Aβ was strongly
Conclusion
The role of cholesterol in amyloidogenic processing of APP came under close scrutiny following the publication of epidemiological studies that correlated cellular cholesterol and AD pathogenesis. Given that cholesterol is one of the major constituent of lipid rafts, the involvement of raft membrane microdomains in APP processing was investigated. Indeed, multiple lines of evidence suggest that amyloidogenic processing of APP is associated with membrane raft microdomains. Spatial segregation of
Acknowledgements
Research in authors' laboratories are supported by NIH grants AG021495 and AG019070, Alzheimer's Association (IIRG to GT; NIRG to KSV) and the American Health Assistance Foundation.
References (97)
- et al.
Amyloid precursor protein trafficking, processing, and function
J. Biol. Chem.
(2008) The g-secretase complex: machinery for intramembrane proteolysis
Curr. Opin. Neurobiol.
(2004)- et al.
Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1
J. Biol. Chem.
(2004) - et al.
The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1
J. Biol. Chem.
(2003) - et al.
The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate
J. Biol. Chem.
(2005) - et al.
beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase
J. Biol. Chem.
(2005) - et al.
Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase
J. Biol. Chem.
(2007) - et al.
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Cell
(1989) - et al.
The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway
J. Biol. Chem.
(1990) - et al.
Phosphorylation of Alzheimer amyloid precursor protein by protein kinase C
Neuroscience
(1992)
Serine phosphorylation of the secreted extracellular domain of APP
Biochem. Biophys. Res. Commun.
The X11 proteins. Abeta production and Alzheimer's disease
Trends Neurosci.
Adaptor protein sorting nexin 17 regulates amyloid precursor protein trafficking and processing in the early endosomes
J. Biol. Chem.
The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production
J. Biol. Chem.
Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein
J. Biol. Chem.
Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase
J. Biol. Chem.
Phosphorylation regulates intracellular trafficking of beta-secretase
J. Biol. Chem.
The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta)
Mol. Cell. Neurosci.
Evidence that production and release of amyloid beta-protein involves the endocytic pathway
J. Biol. Chem.
Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo
Neuron
Metabolism of the “Swedish” amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus
J. Biol. Chem.
Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes
J. Biol. Chem.
Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal
J. .Lipid Res.
Lipid rafts and the control of neurotrophic factor signaling in the nervous system: variations on a theme
Curr. Opin. Neurobiol.
Spatial and temporal control of signaling through lipid rafts
Curr. Opin. Neurobiol.
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels
Biochem. Biophys. Res. Commun.
Statins and the risk of dementia
Lancet
Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol
Exp. Neurol.
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
Neurobiol. Dis.
A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease
Neurobiol. Dis.
Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion
J. Biol. Chem.
Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism
J. Biol. Chem.
Modulation of amyloid precursor protein cleavage by cellular sphingolipids
J. Biol. Chem.
Detergent-resistant membranes should not be identified with membrane rafts
Trends Biochem. Sci.
Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function
J. Lipid Res.
Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
Curr. Biol.
Spatial segregation of g-secretase and substrates in distinct membrane domains
J. Biol. Chem.
Cholesterol depletion of enterocytes. Effect on the Golgi complex and apical membrane trafficking
J. Biol. Chem.
Effects of cholesterol depletion and increased lipid unsaturation on the properties of endocytic membranes
J. Biol. Chem.
Statin effects on cholesterol micro-domains in brain plasma membranes
Biochem. Pharmacol.
Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated
J. Biol. Chem.
Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production
J. Biol. Chem.
Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts
J. Biol. Chem.
Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains
Neurobiol. Dis.
S-palmitoylation of gamma-secretase subunits nicastrin and APH-1
J. Biol. Chem.
EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains
Neuron
Über eine eigenartige Erkrankung der Hirnrinde
Allgemeine Z. Psych. Psychisch-Gerichtliche Med.
BACE1: the beta-secretase enzyme in Alzheimer's disease
J. Mol. Neurosci.
Cited by (235)
Role of rafts in neurological disorders
2023, NeurologiaReorganization of the outer layer of a model of the plasma membrane induced by a neuroprotective aminosterol
2023, Colloids and Surfaces B: BiointerfacesCyclodextrins as promising therapeutics against cholesterol overload
2022, Cholesterol: From Chemistry and Biophysics to the ClinicSwinging and tumbling of multicomponent vesicles in flow
2022, Journal of Fluid Mechanics